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A2-month-old infant with progressive idiopathic dila-tive cardiomyopathy (iDCM) who was listed for hearttransplantation recovered dramatically from end-stageheart failure after pulmonary artery banding (PAB).
To our knowledge, the use of PAB to treat left-sided iDCM has not
been described in the literature.
Clinical Summary
The patient presented
during fetal life with
massive dilation and
reduced systolic func-
tion of the left ventricle
(LV). At 35 weeks of
gestation, delivery became necessary because of progressive dete-
rioration of heart function. A postnatal echocardiogram showed an
extremely dilated LV (Figure 1, A) with an ejection fraction of
13%. The male newborn (weight 2370 g) was treated with con-
trolled ventilation, inotropics, and prostaglandin E1 for contribu-
tion of the right ventricle (RV) to cardiac output through the
arterial duct. When secondary causes of dilative cardiomyopathy
were ruled out, the patient was listed for heart transplantation; 2
months after this, we decided to perform a central PAB, because
PAB is an established approach for patients with a morphologic
RV in systemic position to retrain the LV and to improve RV
failure and ameliorate tricuspid insufficiency.1,2 The local ethics
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Figure 1. Treatment of idiopathic di-
lated cardiomyopathy with PAB. Echo-
cardiography demonstrates the ex-
tremely dilated LV before PAB was
surgically performed. The measured LV
end-diastolic diameter was 41 mm.
Both the LV posterior wall dimension
and the diastolic dimension of the in-
terventricular septum were 3 mm (api-
cal 4-chamber view) (A). Six weeks
after banding, echocardiographic as-
sessment revealed a decrease of the
LV end-diastolic diameter to 30 mm
with a significant improvement of sys-
tolic function (m-mode, 2-dimensional
recording) (B). At the age of 6 months,
cardiac magnetic resonance imaging
showed a concentric hypertrophy of
the LV with a normal systolic function,
instead of the expected RV hypertrophy
with a remaining LV dilation. Magnetic
resonance imaging measurements re-
vealed an LV end-diastolic diameter of
24 mm, LV posterior wall dimension of 9 mm, and interventricular septal defect of 12 mm. The calculated ejection fraction was 62%
(systolic and diastolic phase in magnetic resonance imaging 4-chamber view) (C).
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committee approved the procedure. Informed consent was ob-
tained from the parents. The intraoperative pressure gradient
across the PAB was adjusted to 45 mm Hg (half systemic), which
increased to 65 mm Hg when the infant was discharged 4 weeks
later. Rehabilitation of the LV shape and improvement of function,
accompanied by a diminution of the mitral regurgitation, were
observed by repositioning of the ventricular septum as an imme-
diate LV-RV cross-talk. At the 6-week and 6-month follow-ups,
dramatic changes of the LV morphology were documented by
echocardiography (Figure 1, B) and magnetic resonance imaging
(Figure 1, C), respectively. At the age of 1 year, the patient
underwent balloon dilatation of the PAB to decrease RV pressure
from the systemic level to a systolic RV pressure of 45 mm Hg.
Magnetic resonance imaging 3 weeks after the intervention
showed a still hypertrophied LV with an ejection fraction of 66%.
Brain natriuretic peptide levels decreased from a 2-peak maximum
of 6910 pg/mL (postnatally) and 2923 pg/mL (before PAB) to
normal values of 87 pg/mL after the intervention, corresponding
with the patient’s excellent clinical condition.
Discussion
This report describes the first-time application of PAB for the
treatment of iDCM in an infant with LV failure who was listed for
heart transplantation. The rationale for such surgical treatment
derives from convincing results with PAB in patients with a
subaortic RV.1,2 We recognize the limitations of a single case
report, but we are convinced that PAB is a promising adjunctive
novel therapy for left-sided iDCM, particularly at this young age.
We found an immediate cross-talk between the pressure-loaded
RV and the dilated LV in terms of resynchronization of the LV by
reshifting the interventricular septum. In addition, PAB had a
direct impact on the mitral regurgitation. In consideration of the
possible long-term perspectives of this approach, the first goal was
to retrain the RV to work in synchrony with the failing LV by
performing a Damus–Kaye–Stansel operation combined with a
Glenn–Shunt in the further follow-up. This idea was created in the
context of our experience with the hybrid strategy in newborns
with hypoplastic left-sided heart complex.3 However, the mecha-
nism of the concentric remodeling with improved function of the
LV in response to the chronic pressure load of the RV was
surprising and led to a change in our decision making only for
unloading the RV by balloon dilation of the pulmonary banding.
However, the mechanism of LV remodeling needs to be eluci-
dated. Synergy among postnatal physiologic cardiac growth, car-
diomyopathic background,4 and changes of biventricular gene
expression in the setting of RV pressure overload5 may play a role.
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